Frank Danger Li, MD, agreed to pay $2.9 million to settle allegations that his companies, Seattle Pain Center and Northwest Analytics, billed government payers for medically unnecessary urine drug tests.
According to the settlement agreement, a policy implemented in 2013 required each patient treated at Seattle Pain centers to have a full urine drug panel each time they saw a provider. Dr. Li’s Northwest Analytics did urine testing for the clinics. The policy, which didn’t meet state standards, resulted in thousands of medically unnecessary tests.
Dr. Li’s seven pain clinics closed in July 2016 after Washington state officials suspended his medical license for improperly monitoring opioid prescriptions. The most recent settlement is a civil resolution and unrelated to criminal investigations or state health regulator actions.
More articles on legal and regulatory issues:
Pennsylvania physician charged in patient’s death
Tennessee hospital settles false billing allegations
Feds charge California physician for allegedly selling fake COVID-19 cure
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.